HCPCS Level II J7202: Factor IX Albumin Fusion Protein (Idelvion) Injection
HCPCS Level II code J7202 describes an injectable recombinant Factor IX albumin fusion protein (Idelvion) supplied per international unit (1 i.u.), used for replacement therapy in patients with hemophilia B; the service is a therapeutic coagulation factor infusion typically administered in outpatient infusion centers, hospital outpatient departments, or specialty clinics.
For related coverage guidance, see recent payer policy updates: Bendamustine Products Coverage Criteria, T-Cell Lymphoma Agents: Beleodaq, Istodax, Lymphir, Poteligeo, and Romidepsin, Brentuximab Vedotin (Adcetris®) Coverage Criteria.
Customize your policy alerts
Sign up for hcpcs J7202 policy alerts
Get alerted when payer policies referencing J7202 are released or updated.
Monitor payer policy activity